Large Outflow of Money Witnessed in St. Jude Medical

St. Jude Medical (STJ) : The value of composite uptick trades was $18.32 million, whereas, the value of composite downtick trades was $29.46 million. The uptick to downtick ratio stood at 0.62 with a negative money flow of ($11.14) Million during Fridays trading session. The block trades money flow was negative ($7.62 million).The uptick to the downtick ratio of 0.1 in block trades signals that the large investors have utilized the rise in the stock to sell.The uptick transaction value stood at $0.83 million. The transaction of the trades on downticks amounted to $8.45 million, which confirms investors selling on the strength of price. St. Jude Medical (STJ) gained 51 cents at $78.65, an increase of 0.65% over the previous days close.


The company Insiders own 4.8% of St. Jude Medical shares according to the proxy statements. Institutional Investors own 82.52% of St. Jude Medical shares.

In a related news, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the officer (VP, Global Quality) of St Jude Medical Inc, Fecho Jeff had sold 10,408 shares worth of $538,198 in a transaction dated February 5, 2016. In this transaction, 10,408 shares were sold at $51.71 per share.

St. Jude Medical (NYSE:STJ): The stock opened at $78.4 and touched an intraday high of $78.74 on Friday. During the day, the stock corrected to an intraday low of $78.26, however, the bulls stepped in and pushed the price higher to close in the green at $78.65 with a gain of 0.65% for the day. The total traded volume for the day was 1,890,972. The stock had closed at $78.14 in the previous trading session.

St. Jude Medical (STJ) has been under a strong bear grip, hence the stock is down -6.13% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 0.31% in the past 1 week. The stock has risen by 0.82% in the past week indicating that the buyers are active at lower levels, but the stock is down -6.26% in the past 4 weeks.

St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal product categories include tachycardia implantable cardioverter defibrillator (ICD) systems, bradycardia pacemaker systems, atrial fibrillation (AF) products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems), vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, heart failure monitoring device and other vascular accessories), structural heart products and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders).

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.